Fig. 2From: Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)Waterfall plot depicting changes in symptom severity scores from baseline to safety follow-up. All patients who completed both MDASI-MPM assessments at baseline and safety follow-up showed symptom worsening (N = 98). About 86% of the patients had a 1-point or greater increase in symptom severity while 65% had a at least a 2-point symptom worseningBack to article page